In addition to CRC, we found that higher PPP2R5C mRNA levels in tumors showed poorer overall survival rates in several other types of cancer, including adrenocortical adenocarcinoma, uveal melanoma, esophageal carcinoma, and kidney carcinoma (Supplementary Fig. 10). Here, PPP2R5C is linked to renal carcinoma.